Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 106 (3) , 490-497
- https://doi.org/10.1016/j.ygyno.2007.04.022
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian CancerClinical Cancer Research, 2006
- Proteomic-Based Discovery and Characterization of Glycosylated Eosinophil-Derived Neurotoxin and COOH-Terminal Osteopontin Fragments for Ovarian Cancer in UrineClinical Cancer Research, 2006
- Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian CancerJournal of Clinical Oncology, 2005
- Potential markers that complement expression of CA125 in epithelial ovarian cancerGynecologic Oncology, 2005
- Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profilingGynecologic Oncology, 2005
- Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinomaGynecologic Oncology, 2004
- Characterization of human mesothelin transcripts in ovarian and pancreatic cancerBMC Cancer, 2004
- Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell AdhesionJournal of Biological Chemistry, 2004
- Status of Tumor Markers in Ovarian Cancer ScreeningJournal of Clinical Oncology, 2003
- Urine β-Core Fragment, a Potential Screening Test for Ectopic Pregnancy and Spontaneous AbortionFetal Diagnosis and Therapy, 1997